ACR issues position statements on drug pricing, step therapy
(HealthDay)—Two position statements developed in relation to drug pricing and step therapy have been issued by the American College of Rheumatology (ACR).
Apr 15, 2019
0
1
(HealthDay)—Two position statements developed in relation to drug pricing and step therapy have been issued by the American College of Rheumatology (ACR).
Apr 15, 2019
0
1
A prostate cancer drug won't be offered on the NHS any earlier in the treatment plans of patients living with the disease in England, after it failed to pass a cost-effectiveness review.
Apr 8, 2019
0
2
Three times a week, Tod Gervich injects himself with Copaxone, a prescription drug that can reduce the frequency of relapses in people who have some forms of multiple sclerosis. After more than 20 years with the disease, ...
Apr 2, 2019
0
1
Tuberculosis is one of the world's deadliest infectious diseases: One-third of the world's population is infected with TB, and more than 1 million people die from the disease every year.
Mar 13, 2019
0
9
A genetic discovery will make treatment for Crohn's disease and ulcerative colitis safer, by identifying patients who are at risk of potentially deadly drug side effects.
Feb 26, 2019
0
1572
(HealthDay)—In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.
Feb 13, 2019
0
1
Anyone keeping tabs on how much they spend at the pharmacy knows that drug costs are rising, but what exactly is driving prices upward is often a mystery.
Jan 11, 2019
0
1
(HealthDay)—Generics make up 80 percent of drug prescriptions filled in the United States and are a big cost savings for consumers.
Oct 24, 2018
0
0
Prescription drug copayments often exceed the retail cost of a drug, a recent USC study reveals. This means that technically an overpayment occurs, and someone—not the patient—keeps the excess payment.
Aug 31, 2018
0
8
(HealthDay)—Outcomes-based pricing does not reduce the costs of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, according to a research letter published online April 3 in the Annals of Internal Medicine.
Apr 3, 2018
0
3